Singular Genomics Systems... (OMIC)
NASDAQ: OMIC
· Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM
Singular Genomics Systems Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 406K | 737K | 442K | 1.08M | 462K | 505K | 863K | 765K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 707K | 915K | 2.58M | 1.54M | 527K | 597K | 807K | 789K | 1.67M | 1.54M | 461K | 364K | 303K | 255K | 211K |
Gross Profit | -301K | -178K | -2.14M | -457K | -65K | -92K | 56K | -24K | -1.67M | -1.54M | -461K | -364K | -303K | -255K | -211K |
Operating Income | -18.07M | -22.8M | -26.85M | -25.28M | -24.54M | -27.6M | -25.38M | -22.53M | -24.69M | -24.24M | -22.02M | -19.67M | -17.46M | -13.88M | -10.26M |
Interest Income | 1.56M | 1.84M | 2.11M | 2.32M | 2.46M | 2.29M | 2M | 1.67M | 1.11M | 428K | 156K | 105K | 84K | 413K | 131K |
Pretax Income | -16.8M | -21.25M | -25.02M | -23.25M | -22.36M | -25.58M | -23.63M | -21.1M | -23.79M | -23.98M | -22.01M | -19.76M | -17.61M | -37.48M | -23.92M |
Net Income | -16.8M | -21.25M | -25.02M | -23.25M | -22.36M | -25.58M | -22.15M | -19.67M | -22.89M | -23.72M | -21.99M | -19.76M | -17.61M | -37.48M | -23.92M |
Selling & General & Admin | 8.2M | 11.9M | 13.21M | 13.13M | 13.25M | 14.89M | 13.2M | 11.75M | 11.96M | 12.18M | 11.38M | 10.22M | 8.55M | 6.2M | 3.65M |
Research & Development | 9.57M | 10.73M | 11.49M | 11.69M | 11.22M | 12.62M | 12.23M | 10.76M | 12.73M | 12.06M | 10.64M | 9.46M | 8.91M | 7.68M | 6.61M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -7K | -23.8M | -11.4M |
Operating Expenses | 17.77M | 22.63M | 24.71M | 24.82M | 24.47M | 27.51M | 25.43M | 22.51M | 24.69M | 24.24M | 22.02M | 19.67M | 17.46M | 13.88M | 10.26M |
Interest Expense | 286K | 286K | 284K | 287K | 285K | 270K | 259K | 243K | 211K | 167K | 142K | 192K | 234K | 232K | 188K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.81M | n/a | n/a | n/a | -8.19M | n/a | n/a | n/a |
Cost & Expenses | 18.48M | 23.54M | 27.29M | 26.36M | 25M | 28.11M | 26.24M | 23.3M | 24.69M | 24.24M | 22.02M | 19.67M | 17.46M | 13.88M | 10.26M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.49M | -1.43M | -904K | -261K | -14K | -364K | 150K | n/a | n/a |
Shares Outstanding (Basic) | 2.5M | 2.48M | 2.47M | 2.45M | 2.44M | 2.42M | 2.4M | 2.39M | 2.37M | 2.36M | 2.37M | 2.41M | 2.39M | 2.33M | 2.27M |
Shares Outstanding (Diluted) | 2.5M | 2.48M | 2.47M | 2.45M | 2.44M | 2.42M | 2.4M | 2.39M | 2.37M | 2.36M | 2.37M | 2.41M | 2.39M | 2.33M | 2.27M |
EPS (Basic) | -6.72 | -8.57 | -10.15 | -9.48 | -9.17 | -10.58 | -9.24 | -8.24 | -9.64 | -10.05 | -9.29 | -8.21 | -7.37 | -16.09 | -10.55 |
EPS (Diluted) | -6.72 | -8.57 | -10.15 | -9.48 | -9.17 | -10.58 | -9.24 | -8.24 | -9.64 | -10.05 | -9.29 | -8.21 | -7.37 | -16.09 | -10.55 |
EBITDA | -14.82M | -19.19M | -23.02M | -21.31M | -20.2M | -23.43M | -21.56M | -19.14M | -21.91M | -22.27M | -21.4M | -19.2M | -17.07M | -36.99M | -23.52M |
EBIT | -16.51M | -20.97M | -24.74M | -22.96M | -22.07M | -25.31M | -23.37M | -20.86M | -23.58M | -23.82M | -21.86M | -19.57M | -17.38M | -37.25M | -23.73M |
Depreciation & Amortization | 1.69M | 1.78M | 1.72M | 1.65M | 1.87M | 1.88M | 1.82M | 1.72M | 1.67M | 1.54M | 461K | 364K | 303K | 255K | 211K |